Rating History for 7/31/2026
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics
(B.Riley - Mayank Mamtani) |
FDMT | New Coverage | Buy (N/A) |
37.00 (N/A) |
9.61 (15.91) |
65.56% | Details | ||
| Acadian Asset Management
(RBC Capital - Kenneth Lee) |
AAMI | Maintain | Sector Perform (N/A) |
80.00 (72.00) |
|
Details | |||
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 717 more... | |||||||||
